Responding to deputy prime minister Winston Peters’ election promise of an annual health checkup, including an annual eye exam, for SuperGold Card holders, the Eye Health Coalition (EHC) presented
A device developed by young Indonesian ophthalmologist Dr Virna Oktariana alongside Western Australia’s Lions Eye Institute (LEI) will make glaucoma treatment more accessible in Indonesia.Launched at
It may sound a challenge akin to patting your head and rubbing your belly, but neuroscientists at Duke University have discovered that your ears move when your eyes do.Even without sound, the eardrums
‘Autofocals’ developed at Stanford University allow wearers to maintain sharp near and far focus, offering a smartglasses solution to existing bifocal, varifocal and progressive lenses.Researcher
For the first time, a part five optometry student, Sushmita Chinchankar, participated in the University’s Rural Health Interprofessional Programme (RHIP) hosted in Whakatāne earlier this year.
Glasses prescribed to young children to correct hyperopia failed to show significant visions benefit after three years of follow-up in a randomised trial in the US.The Ohio State University study lead
A US study showed increased physical activity slowed rates of visual field loss in patients with glaucoma.Patients who took an additional 5000 daily steps or 2.6 hours of physical activity decreased
Guardion Health Sciences has launched GlaucoCetin, a supplement shown in a small clinical trial to positively affect the optic nerve cells in glaucoma patients.Created by Dr Robert Ritch of New York
New Zealander Steve Stenersen is the only southern hemisphere optician in the running for the 2019 IOA/Silmo Optician of the Year title to be announced at the annual Paris event this
All University of Auckland first year students can now take a general course in human vision.Convened by Associate Professor Sam Schwarzkopf, Professor Steven Dakin and Dr Misha Vorobyev, the new
FDA approval has been granted for Soliris injections to treat neuromyelitis optica spectrum disorder (NMOSD), an autoimmune disease of the central nervous system that affects the optic nerves and
Trials of a new acuity testing device have successfully increased health study participation rates among Māori.Dr Jason Turuwhenua, from Auckland University’s Bioengineering Institute and Ngāi Tūhoe
